Satellos Bioscience Inc · TSX:MSCL

Satellos Bioscience Inc financial statements

Satellos Bioscience Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue000025.0K
Cost of revenue5.09K7.00K3.73M165.7K4223.06K1.54K23.5K27.4K
Gross profit-5.09K-8.82M-3.73M-165.7K-422-3.06K-1.54K-23.5K-27.4K
Research and development18.4M14.4M8.82M2.59M1.88M892.8K917.5K1.42M786.6K564.2K
Selling, general and administrative7.44M6.06M4.66M1.13M182.4K857.4K
Operating income-26.5M-20.4M-15.5M-8.43M-6.65M-2.77M-2.21M-2.20M-1.47M-1.23M
Depreciation and amortization4.00K15.0K7.00K337.0K165.7K4227341.54K23.5K27.4K
EBITDA-26.5M-20.4M-15.5M-8.09M-6.48M-2.77M-2.20M-2.20M-1.45M-1.20M
Interest expense177.0K50.9K985.3K23.0K
Income before tax-24.7M-20.6M-15.9M-11.3M-15.5M-1.58M-2.20M-1.70M-1.24M-1.49M
Income tax172.0K177.0K5.00K-42.4K-270.6K-264.8K
Net income-24.9M-20.6M-15.9M-11.3M-15.5M-1.58M-1.94M-1.70M-1.24M-1.49M
Earnings per share, basic-1.70-2.16-2.21-3.81-7.73-0.58-0.71-4.84-3.51-4.23
Earnings per share, diluted-1.70-2.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents9.80M40.1M22.1M1.92M4.87M717.5K399.1K10.1K1.13M2.36M
Short-term investments17.9M8.47M17.5M2.36M
Receivables369.3K583.0K260.4K528.0K409.1K12.5K129.7K88.4K37.1K
Inventory-583.0K-260.0K-528.0K-409.1K
Current assets31.9M50.7M40.3M2.23M5.44M1.13M1.07M175.0K1.37M2.42M
Property, plant and equipment5.00K4.00K13.8K5.85K
Goodwill-190
Total assets31.9M50.7M44.3M6.20M12.6M1.13M1.07M178.1K1.37M2.45M
Accounts payable4.11M3.58M1.04M1.47M1.13M128.5K629.2K
Current liabilities4.11M3.58M3.62M2.83M2.10M220.0K664.8K802.5K288.2K138.1K
Total debt1.09M
Total liabilities4.11M3.58M3.62M2.83M2.10M1.31M664.8K802.5K288.2K138.1K
Shareholders' equity27.8M47.2M40.7M3.37M10.5M-183.8K408.6K-624.4K1.09M2.31M
Shares outstanding14.6M7.20M2.97M2.01M2.74M2.74M351.9K351.9K351.9K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Cash from operations-23.6M-18.3M-14.4M-5.64M-5.03M-1.66M-1.92M-1.10M-1.33M
Capital spending-6.00K-4.00K-18.0K-3.00K-7.25K0-771-3.19K-4.03K
Free cash flow-23.6M-18.3M-14.5M-5.79M-5.04M-1.66M-1.93M-1.11M-1.34M
Cash from investing-9.42M4.66M-17.5M-3.00K1.74M-771-3.19K-4.03K
Cash from financing2.24M37.6M51.0M2.77M7.45M1.98M1.16M
Dividends paid00
Share buybacks2.24M37.0M2.02M
Change in cash-30.3M23.4M20.1M-2.95M4.15M318.4K-767.9K-1.12M-366.5K